Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

SNAP-8719: a valuable tool for studying alpha1D-adrenoceptor function

Sep. 2, 1998

GeneMedicine receives patent protection for gene delivery technologies

Sep. 1, 1998

Ciclosporin oral solution dispenser cleared by the FDA for marketing

Sep. 1, 1998

MorphoSys and LeukoSite enter collaboration agreement

Aug. 28, 1998

U.S. patent will issue for novel lipid-based gene delivery systems

Aug. 27, 1998

Anergen claims production methods for AnergiX compounds

Aug. 25, 1998

Phytera and Tsumura Juntendo expand research collaboration

Aug. 24, 1998

International team identifies selective P2X antagonists

Aug. 21, 1998

MorphoSys and Pharmacia & Upjohn suspend joint research program

Aug. 20, 1998

Genzyme division and Bayer enter into genomics agreement

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...